A randomized, double-blind, placebo-controlled trial of intravenous hydrocortisone in reducing human anti-chimeric antibody following infliximab therapy
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 120 (5) , A618-A619
- https://doi.org/10.1016/s0016-5085(08)83077-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: